AbbVie
ABBV
#31
Rank
HK$2.360 T
Marketcap
HK$1,336
Share price
-1.23%
Change (1 day)
5.33%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: HK$2.360 Trillion

As of January 2025 AbbVie has a market cap of HK$2.360 Trillion. This makes AbbVie the world's 31th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$2.360 T-3.35%
2024HK$2.442 T14.29%
2023HK$2.136 T-4.31%
2022HK$2.233 T19.64%
2021HK$1.866 T27.28%
2020HK$1.466 T43.8%
2019HK$1.019 T-4.48%
2018HK$1.067 T-11.49%
2017HK$1.206 T52.86%
2016HK$789.13 B6.76%
2015HK$739.18 B-8.49%
2014HK$807.76 B24.26%
2013HK$650.03 B55.38%
2012HK$418.35 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of AbbVie was reported to be:

HK$2.389 Trillion
by Yahoo Finance info icon info icon
HK$2.389 Trillion
by CompaniesMarketCap info icon info icon
HK$2.389 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$1.160 T-50.84%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$888.86 B-62.34%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$5.081 T 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.138 T-51.75%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$891.13 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$159.45 B-93.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$531.03 B-77.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$1.608 T-31.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$112.92 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA